Lioresal and Deafness neurosensory - a phase IV clinical study of FDA data
We study 23,972 people who take Lioresal or have Deafness neurosensory. No report of Deafness neurosensory is found in people who take Lioresal.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Lioresal?
Lioresal has active ingredients of baclofen. It is often used in multiple sclerosis. eHealthMe is studying from 19,861 Lioresal users for its effectiveness, alternative drugs and more.
What is Deafness Neurosensory?
Deafness neurosensory is found to be associated with 1,393 drugs and 842 conditions by eHealthMe.
Do you take Lioresal and have Deafness neurosensory?Check whether Deafness neurosensory is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Deafness neurosensory and when was it recovered:
Expand to all the drugs that have ingredients of baclofen:
Alternative drugs to, pros and cons of Lioresal:
- Lioresal (19,861 reports)
Deafness neurosensory treatments and more:
- Deafness neurosensory (4,111 reports)
COVID vaccines that are related to Deafness neurosensory:
- Deafness neurosensory in Moderna COVID Vaccine
- Deafness neurosensory in Pfizer BioNTech Covid Vaccine
- Deafness neurosensory in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Deafness neurosensory:
All the conditions that are associated with Deafness neurosensory:
How the study uses the data?
The study uses data from the FDA. It is based on baclofen (the active ingredients of Lioresal) and Lioresal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gastroesophageal Reflux Disease and Peritoneal Abscess - a second ago
- Fosrenol and Tooth Abscess - 2 seconds ago
- Lamotrigine and Infusion Site Mass - 7 seconds ago
- Diovan Hct and Haloperidol drug interaction - 10 seconds ago
- Orencia and Heart Rate Decreased - 12 seconds ago
- Miralax and Fluphenazine Decanoate drug interaction - 14 seconds ago
- Cimetidine and Hysterectomy - 18 seconds ago
- Metformin vs. Glucotrol - 19 seconds ago
- Oxaliplatin and Malignant Hypertension (Arteriolar Nephrosclerosis) - 23 seconds ago
- Kenalog and High Density Lipoprotein Decreased - 25 seconds ago